Hematology NewsLong view shows doubling of survival in non-Hodgkin lymphomaJanuary 30, 2017Aggressive LymphomasLymphoma & Plasma Cell DisordersIndolent LymphomaHodgkin Lymphoma
Hematology NewsHodgkin lymphoma survival has nearly tripled since the 1950sJanuary 30, 2017Indolent LymphomaLymphoma & Plasma Cell DisordersAggressive LymphomasHodgkin Lymphoma
Hematology NewsFDA approves ibrutinib for refractory MZLJanuary 19, 2017Indolent LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology NewsVIDEO: Obinutuzumab bests rituximab for PFS in follicular lymphomaDecember 6, 2016Indolent LymphomaLymphoma & Plasma Cell DisordersMantle Cell LymphomaFollicular Lymphoma
Hematology NewsAntibody face-off in follicular lymphoma gives PFS, but not OS, edge to obinutuzumabDecember 5, 2016Indolent LymphomaLymphoma & Plasma Cell DisordersMantle Cell LymphomaFollicular Lymphoma
Hematology NewsExpert panel offers treatment recommendations in Waldenström macroglobulinemiaSeptember 27, 2016Indolent LymphomaLymphoma & Plasma Cell Disorders
Oncology PracticeTriptorelin doesn’t prevent ovarian failure in young women treated for lymphomaJuly 28, 2016Gynecologic CancerLymphoma & Plasma Cell DisordersPatient & Survivor CareIndolent Lymphoma
Hematology NewsLong-term analysis shows dwindling RT benefit for DLBCLJuly 9, 2016Indolent LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsBendamustine-based chemotherapy induces high CR rate in relapsed HLJuly 8, 2016Indolent LymphomaAggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsAdding obinutuzumab to bendamustine boosts progression-free survival in rituximab-refractory indolent non-Hodgkin lymphomaJune 28, 2016Indolent LymphomaLymphoma & Plasma Cell DisordersHodgkin Lymphoma
Hematology NewsFollicular lymphoma with histologic transformation may merit ASCTJune 14, 2016Indolent LymphomaLymphoma & Plasma Cell DisordersAggressive LymphomasFollicular Lymphoma
Hematology NewsBrentuximab vedotin boosted PET-negative rate in HodgkinJune 6, 2016Indolent LymphomaLymphoma & Plasma Cell DisordersHodgkin Lymphoma
Hematology NewsEnzastaurin flops as maintenance in treated DLBCLMay 23, 2016Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsEpstein-Barr virus DNA in plasma reliably detects EBV-positive lymphoproliferative disordersMay 11, 2016Indolent LymphomaAggressive Lymphomas
Hematology NewsLow transformation rate in nodular lymphocyte–predominant Hodgkin lymphomaApril 28, 2016Indolent LymphomaLymphoma & Plasma Cell DisordersHodgkin LymphomaFollicular Lymphoma
